Generative AI adoption reached 35% of enterprises, while 47% of U.S. consumers trust healthcare professionals more than any other source when choosing supplements. The market is also expanding, with the global dietary supplements industry projected to grow at a 7.5% CAGR from 2024 to 2030 and major U.S. sales reaching $14.7 billion for botanical products in 2023. That mix of faster adoption and trust-driven purchasing sits alongside rising scrutiny of supplement safety signals.
Key Takeaways
- 7.5% CAGR expected for the global dietary supplements market from 2024 to 2030
- $14.7 billion U.S. sales of dietary supplements containing botanicals in 2023
- $8.6 billion U.S. dietary supplement sales for proteins/fitness products in 2023
- 23% of U.S. adults used dietary supplements in the past month (NHIS 2022)
- 47% of consumers say they trust information from healthcare professionals more than other sources when choosing supplements
- 68% of executives believe generative AI will transform customer experience within 1–2 years (McKinsey, 2023)
- Companies with faster incident response saved $1.2 million compared to those with slower response (IBM 2024)
- 63% of organizations expect AI to reduce operating costs (Gartner survey, 2024)
- AI adoption in marketing increased from 29% to 44% from 2022 to 2023 (Gartner marketing technology survey trend reported 2023)
- 40% of healthcare organizations use AI in at least one workflow (AMA STEPS Forward survey, 2023)
- 19% of adults took 'other' supplements (NHIS 2022)
- FDA’s dietary supplement adverse event reports include 56% reporting that the adverse event was serious (FDA DSMA analysis, 2023)
- FDA reports dietary supplements accounted for 33% of total food import detentions in 2023 related to 'not in compliance with regulations' (FDA data)
- FDA conducted 1.2 million inspections of dietary supplement-related facilities since DS registration began (FDA facility inspection reporting)
Rapid AI adoption and growing demand are reshaping dietary supplements, with strong market growth and rising adverse event reporting.
Related reading
01 · Category
Market Size3 stats
01
7.5% CAGR expected for the global dietary supplements market from 2024 to 2030
02
$14.7 billion U.S. sales of dietary supplements containing botanicals in 2023
03
$8.6 billion U.S. dietary supplement sales for proteins/fitness products in 2023
Interpretation
Market Size Interpretation
From a market size perspective, the global dietary supplements market is projected to grow at a 7.5% CAGR from 2024 to 2030, supported by large U.S. categories such as $14.7 billion in botanicals in 2023 and $8.6 billion in proteins and fitness products that together signal strong demand for AI-driven targeting and optimization.
02 · Category
Industry Trends6 stats
01
23% of U.S. adults used dietary supplements in the past month (NHIS 2022)
02
47% of consumers say they trust information from healthcare professionals more than other sources when choosing supplements
03
68% of executives believe generative AI will transform customer experience within 1–2 years (McKinsey, 2023)
04
FDA listed 500+ dietary supplement recalls for mislabeling/adulteration between 2020 and 2023 (FDA recall database count by category)
05
FDA recalled 110 dietary supplement products in 2023 due to misbranding/label issues (FDA recall database filtered by year)
06
Generative AI adoption reached 35% of enterprises in 2024 (Gartner enterprise AI survey, 2024)
Interpretation
Industry Trends Interpretation
With 68% of executives expecting generative AI to transform customer experience within 1 to 2 years and 35% of enterprises already adopting it by 2024, the supplement industry is trending toward AI powered engagement while still navigating ongoing trust and compliance pressures reflected by FDA recalls totaling 500 plus from 2020 to 2023.
03 · Category
Cost Analysis2 stats
01
Companies with faster incident response saved $1.2 million compared to those with slower response (IBM 2024)
02
63% of organizations expect AI to reduce operating costs (Gartner survey, 2024)
Interpretation
Cost Analysis Interpretation
From a cost analysis perspective, the data suggests AI can materially cut expenses since 63% of organizations expect it to reduce operating costs and faster incident response can save $1.2 million compared with slower response.
More related reading
04 · Category
User Adoption5 stats
01
AI adoption in marketing increased from 29% to 44% from 2022 to 2023 (Gartner marketing technology survey trend reported 2023)
02
40% of healthcare organizations use AI in at least one workflow (AMA STEPS Forward survey, 2023)
03
19% of adults took 'other' supplements (NHIS 2022)
04
As of 2024, 47% of organizations use AI for customer service automation (Gartner forecast, 2024)
05
33% of U.S. consumers say they would pay more for supplements with verifiable testing/third-party certification (2022 survey)
Interpretation
User Adoption Interpretation
The user adoption data shows a clear momentum, with AI marketing usage rising from 29% in 2022 to 44% in 2023 and 47% of organizations using AI for customer service automation by 2024, indicating that AI is moving from early experiments into mainstream supplement and related customer-facing workflows.
05 · Category
Performance Metrics4 stats
01
FDA’s dietary supplement adverse event reports include 56% reporting that the adverse event was serious (FDA DSMA analysis, 2023)
02
FDA reports dietary supplements accounted for 33% of total food import detentions in 2023 related to 'not in compliance with regulations' (FDA data)
03
FDA conducted 1.2 million inspections of dietary supplement-related facilities since DS registration began (FDA facility inspection reporting)
04
10% year-over-year increase in dietary supplement adverse event reporting in 2022 compared with 2021 (FDA DSMA annual reporting trend, 2022)
Interpretation
Performance Metrics Interpretation
Performance Metrics show that dietary supplement risk and regulatory pressure are rising, with a 10% year over year increase in adverse event reporting in 2022 and supplements accounting for 33% of 2023 import detentions, underscoring why AI monitoring and detection must keep pace with expanding enforcement signals.
report visual · Key figures
AI Adoption and Market Momentum in Supplements
Generative AI adoption and broader AI-driven expectations are accelerating—while the supplement market continues to grow.
29%
AI adoption in marketing increased from 29% to 44% from 2022 to 2023 (Gartner marketing technology survey trend reported
35%
Generative AI adoption reached 35% of enterprises in 2024 (Gartner enterprise AI survey, 2024)
47%
As of 2024, 47% of organizations use AI for customer service automation (Gartner forecast, 2024)
7.5%
7.5% CAGR expected for the global dietary supplements market from 2024 to 2030
source-verifiedgartner.com · grandviewresearch.com2024
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Karl Becker. (2026, February 13). AI In The Supplement Industry Statistics. Gitnux. https://gitnux.org/ai-in-the-supplement-industry-statistics
MLA
Karl Becker. "AI In The Supplement Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/ai-in-the-supplement-industry-statistics.
Chicago
Karl Becker. 2026. "AI In The Supplement Industry Statistics." Gitnux. https://gitnux.org/ai-in-the-supplement-industry-statistics.
Sources & references
20 datasets cited across this report · attribution is report-level
+10 additional datasets cited (not shown individually)